Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
How Durable Is Cryoballoon PVI? Insights From 8-Year AF Data
Author(s): Marco Schiavone , Claudio Tondo Added: 2 weeks ago
Dr Marco Schiavone (Centro Cardiologico Monzino IRCCS, Milan, IT) and Dr Claudio Tondo (Monzino Cardiologic Centre, Milan, IT) discuss long-term durability data from an 8-year follow-up study of cryoballoon pulmonary vein isolation for atrial fibrillation.In this Journal Club session, the experts dig into real-world evidence on the extended durability of cryoballoon ablation, tackling key… View more

Electrophysiology & Arrhythmia
TAVR vs Surgery: No Difference at 7 Years in Low-Risk AS
Added: 1 week ago Source:  Transcatheter Academy
Seven-year follow-up data from the PARTNER 3 trial shows no significant difference in key outcomes between transcatheter aortic-valve replacement (TAVR) and surgical aortic-valve replacement (SAVR) for low-risk patients with severe, symptomatic aortic stenosis.¹ This long-term assessment provides further insight into valve durability and clinical outcomes, building on previous 5-year data which… View more

Intervention
TCT 25 Structural Interventions Highlights
Author(s): Nadira Hamid , Rahul P Sharma Added: 4 months ago
TCT 2025 — Dr Nadira Hamid (Minneapolis Heart Institute, US) and Dr Rahul P Sharma (Stanford University, US) review the late-breaking trial data shaping the future of structural heart disease.The discussion highlights real-world results from TRISCEND and TRILUMINATE in tricuspid disease, 7-year PARTNER 3 durability outcomes in TAVR, national prevalence insights from the PREVUE-VALVE study, and… View more

Intervention
Will PFA Redefine AF Ablation Strategies in 2026?
Author(s): Tina Baykaner , Added: 4 weeks ago
AF Symposium 2026 - Pulsed field ablation in atrial fibrillation: Will it Redefine AF Ablation Strategies?Arrhythmia Academy board member Dr Tina Baykaner (Stanford University, Stanford, CA, US) is joined by Dr Melanie Gunawardene (CCB Frankfurt und Main-Taunus, Frankfurt, DE) exploring whether pulsed field ablation will fundamentally transform atrial fibrillation ablation strategies in 2026.This… View more

Electrophysiology & Arrhythmia
Aditi Balakrishna headshot
Job title: Assistant Professor of Anesthesiology, Division of Critical Care
Dr. Balakrishna is an intensivist and anesthesiologist at Vanderbilt University Medical Center, where she attends in the surgical cardiovascular ICU and serves as an attending on the ECMO transport team. She is also the Associate Program Director of the Anesthesiology Critical Care Medicine fellowship program and the Quality and Patient Safety Director for the Department of Anesthesiology. She… View more
EHRA 24: Ablation Strategies for Repeat Procedures in Recurrent AF
Author(s): Boris Schmidt Added: 1 year ago
EHRA 24 - Investigator, Dr Boris Schmidt (Cardioangiologisches Centrum Bethanien, DE) is interviewed on ablation strategies for repeat procedures in patients with recurrent atrial fibrillation (AF).The ASTRO trial is a multi-centre prospective randomized study that enrolled 256 patients with drug-refractory AF despite previous AF ablation. The trial showed no statistically significant differences… View more

Electrophysiology & Arrhythmia
EuroPCR 25: LANDMARK 1Y Outcomes
Author(s): Patrick W Serruys Added: 9 months ago
EuroPCR 25 - Novel Myval THV shows non-inferiority at one year compared to established valves in severe aortic stenosis.We are joined by Dr Patrick Serruys (Erasmus University Medical Center, Rotterdam, NL) to discuss key findings from the LANDMARK trial.This multinational, multicentric, randomized controlled trial compared the safety and effectiveness of the Myval THV Series against contemporary… View more

Intervention

Vascular Disease and Surgery
ESC HF 25: CRISPR in ATTR-CM: Hereditary vs Wild-Type
Author(s): Marianna Fontana Added: 10 months ago
ESC HF 25 - A study investigating CRISPR gene editing with nexiguran ziclumeran in ATTR cardiomyopathy demonstrated favourable safety and tolerability, with consistent reductions in serum TTR in both wild-type and variant disease.Prof Marianna Fontana (University College London, UK) joins us to discuss the key findings from a two-part, open-label, phase 1 study investigating the treatment effect,… View more

Heart Failure
Lifetime Management Strategies in TAVI with Dr Mohamed Marwan
Author(s): Mohamed Marwan Added: 6 months ago
Explore the evolving paradigm of lifetime management in TAVI with Dr Mohamed MarwanThis presentation addresses the critical shift from single-procedure focus to comprehensive lifetime planning in TAVI management. As guidelines expand to include patients as young as 65 years old, Dr Marwan examines the unique considerations that arise when treating more active individuals who may require future… View more

Imaging & Diagnostics

Intervention
TCT 24: The CLASP IID 2-Year RCT and Registry Outcomes
Author(s): Firas Zahr Added: 1 year ago
TCT Conference 24 - Two-year outcomes of CLASP IID shows that the Edwards PASCAL system was noninferior to the Abbott Mitraclip system in transcatheter mitral valve repair for mitral regurgitation.Dr Firas Zahr (Oregon Health and Science University, US) joins us onsite at TCT Conference to discuss the outcomes from the CLASP IID 2 Year RCT and Registry (NCT02371512; Edwards Lifesciences).CLASP… View more

Intervention